Clinical Molecular Diagnostics 2021
DOI: 10.1007/978-981-16-1037-0_42
|View full text |Cite
|
Sign up to set email alerts
|

Reproductive Organ Cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 47 publications
0
1
0
Order By: Relevance
“…CSF‐CTCs are potential biomarkers for BC diagnosis and prognosis. 28 Our previous study had showed the characteristics of LC CSF‐CTCs, here we focused on BC CSF‐CTCs. We identified BC‐LM CSF‐CTCs by epithelial cell markers ( EPCAM, CDH1, KRT18 and KRT8 ) expression and a higher variable of copy number variations (CNVs) than normal immune cells (Figure S4 ).…”
Section: Resultsmentioning
confidence: 99%
“…CSF‐CTCs are potential biomarkers for BC diagnosis and prognosis. 28 Our previous study had showed the characteristics of LC CSF‐CTCs, here we focused on BC CSF‐CTCs. We identified BC‐LM CSF‐CTCs by epithelial cell markers ( EPCAM, CDH1, KRT18 and KRT8 ) expression and a higher variable of copy number variations (CNVs) than normal immune cells (Figure S4 ).…”
Section: Resultsmentioning
confidence: 99%